About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 440 record(s)
Req # A-2020-57
All records describing the isolation of a SARS-CoVZ / Covid-19 virus, directly from a sample taken from a diseased patient, where the patient sample was not first combined with any source of other genetic material (e.g., monkey kidney cells aka Vero cells, liver cells or suchlike). Please note that the term ”isolation” is used in the everyday sense of the word, i.e., the act of separating a thing or things from everything else. I am not requesting records where ”isolation of SARS-CoVZ / Covid-19” refers instead to the culturing of something, the performance of an amplification test (e.g., a PCR test), or the sequencing of something.Organization: National Research Council Canada
January 2021
Req # A-2020-18438
Copies of all briefing notes, memos, PowerPoints, policy briefs and reports submitted to the Health Minister from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
January 2021
Req # A-2020-18441
Copies of all reports, briefing notes, policy briefs, PowerPoints, emails (to and from Mitchell Levine) and other similar documents discussing the origin and adoption of pharmacoeconomics into the PMPRB guidelines from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
January 2021
Req # A-2020-19861
Copies of all reports, briefing notes, policy briefs, PowerPoints, emails (to, from and cc'ing Douglas Clark) and other similar documents discussing the origin and adoption of pharmacoeconomics into the PMPRB guidelines from June 1, 2019 to December 9, 2020. Include, but do not limit the scope of the request to, reports discussing the origin and adoption of the QALY.Organization: Patented Medicine Prices Review Board Canada
January 2021
Req # A-2020-26
From January 1, 2011 to September 3, 2020: 1. The Translation Bureau's “translation memory” tool, and in particular the “Megacorpus”; 2. The Translation Bureau's neural translation tool; 3. The work carried out, for the evaluation of the tools, by the NRC 4. An economic analysis, if applicable, of the impact on salaried translators (CNRC-BT) as well as contract workers; 5. Document search - reports, briefings and memos - in final version.Organization: National Research Council Canada
December 2020
Req # A-2020-40
Copies of all analysis related to proposed changes to the National Building Code 2020; include any analysis or estimates on what the proposed changes would do to the cost of a new home in Canada.Organization: National Research Council Canada
December 2020
Req # A-2020-42
Briefing note, "Approval of the Evaluation of the Human Health Therapeutics Research Centre", Ref # BN20-09-52Organization: National Research Council Canada
December 2020
Req # A-2020-18432
Copies of the daily calendar meetings, calls and other taskings for Mitchell Levine from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18433
Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18434
Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.Organization: Patented Medicine Prices Review Board Canada
December 2020